DHP Korea Co. Ltd (131030) - Total Liabilities

Latest as of September 2025: ₩25.12 Billion KRW ≈ $17.03 Million USD

Based on the latest financial reports, DHP Korea Co. Ltd (131030) has total liabilities worth ₩25.12 Billion KRW (≈ $17.03 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

DHP Korea Co. Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how DHP Korea Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See DHP Korea Co. Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

DHP Korea Co. Ltd Competitors by Total Liabilities

The table below lists competitors of DHP Korea Co. Ltd ranked by their total liabilities.

Company Country Total Liabilities
Mandom Indonesia Tbk
JK:TCID
Indonesia Rp530.70 Billion
Enex Co.Ltd
KO:011090
Korea ₩86.81 Billion
Mofast AB
ST:MOFAST
Sweden Skr1.53 Billion
JAG Bhd
KLSE:0024
Malaysia RM164.49 Million
Taiwan Pelican Express Co Ltd
TW:2642
Taiwan NT$1.85 Billion
Versatile Creative Bhd
KLSE:4995
Malaysia RM91.12 Million
Atlas Resources Tbk
JK:ARII
Indonesia Rp509.35 Million
Asian Insulators PCL
BK:AI
Thailand ฿519.74 Million

Liability Composition Analysis (2014–2024)

This chart breaks down DHP Korea Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see DHP Korea Co. Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.49 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.17 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.14 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how DHP Korea Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for DHP Korea Co. Ltd (2014–2024)

The table below shows the annual total liabilities of DHP Korea Co. Ltd from 2014 to 2024.

Year Total Liabilities Change
2024-12-31 ₩22.77 Billion
≈ $15.43 Million
+51.69%
2023-12-31 ₩15.01 Billion
≈ $10.17 Million
+27.49%
2022-12-31 ₩11.77 Billion
≈ $7.98 Million
-9.56%
2021-12-31 ₩13.02 Billion
≈ $8.82 Million
+18.19%
2020-12-31 ₩11.01 Billion
≈ $7.46 Million
-1.85%
2019-12-31 ₩11.22 Billion
≈ $7.60 Million
+24.63%
2018-12-31 ₩9.00 Billion
≈ $6.10 Million
+12.31%
2017-12-31 ₩8.02 Billion
≈ $5.43 Million
-6.70%
2016-12-31 ₩8.59 Billion
≈ $5.82 Million
+12.26%
2015-12-31 ₩7.65 Billion
≈ $5.19 Million
-29.80%
2014-12-31 ₩10.90 Billion
≈ $7.39 Million
--

About DHP Korea Co. Ltd

KQ:131030 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$63.33 Million
₩93.45 Billion KRW
Market Cap Rank
#21057 Global
#1193 in Korea
Share Price
₩6110.00
Change (1 day)
+0.49%
52-Week Range
₩5490.00 - ₩19260.00
All Time High
₩19260.00
About

OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name. The company… Read more